15 % of Black Women to 7 % of White Women are diagnosed with Breast Cancer. Can Genomics be the Tool to low the rate in which black women are dia

15 percent of Black Women to 7 percent of White Women are diagnosed with Breast Cancer. Can Genomics be the tool to low the rate in which black women are diagnosed with Breast Cancer and extend their lives.

We know that there are 194,280 Americans will be diagnosed with breast cancer this year and 40,610 will die from the disease. 15 percent Black to 7 percent White.

Some guidelines recommend that Cancer stem cells is the fuel that grow Breast Cancer tumor's. Others guidelines recommend that bone mineral density is the fuel that grows tumors.
Chemotherapies do not work against these cells, which is why cancer recurs and spreads. Hybrid Medical Analytics believe that eliminating the cancer stem cells is key to controlling cancer.

21 percent of black women and 15 percent of white women do not receive the minimum expected treatment. Black Women have shorter survival and higher mortality observed for black women
compared to white women.The correlation of lower social class and the lack of Health Care equals less screening, and later stage diagnosis.

Can Genomics be the answer for Black women ? Genomics Science looks at groups of genes and how active they are. This activity can influence how a cancer is likely to grow and respond to treatment.
Hybrid Medical Analytics Genomics Science looks at 21 genes in a patient’s breast cancer tumor in trials to understand how these genes interact and influence the tumor’s behavior.

Genomics is personalized treatment that will reduce the rate of cancer for Black Women.

Tamoxifen and Raloxifene works the same for Balck and White Women, but to many Black Women say the treatment can be toxic. Black Women state that too much toxicity leads to not taking the treatment.

Hybrid Medical Analytics Area of Research

* Breast cancer
* Endocrine system cancer
* Gastrointestinal cancer
* Genitourinary cancer
* Gynaecological cancer
* Haematological cancer
* Head and neck cancer
* Neurooncology
* Paediatric oncology
* Thoracic oncology
* Sarcoma
* Skin cancer
* Epidemiology, cancer prevention, and cancer control
* Supportive care
* Imaging
* Health-care systems